PLx Pharma Historical PE Ratio image   This PLXP PE ratio history page last updated 11/11/2022
PLx Pharma Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/10/2022
0.60-0.37-1.48NA
Q2 2022
8/12/2022
1.64-0.52-2.08NA
Q1 2022
5/13/2022
2.59-0.66-2.64NA
Q4 2021
3/11/2022
4.05-0.73-2.92NA
Q3 2021
11/12/2021
12.28-0.37-1.48NA
Q2 2021
8/6/2021
19.09-0.79-3.16NA
Q1 2021
5/14/2021
11.07-0.73-2.92NA
Q4 2020
3/12/2021
7.98-0.87-3.48NA
Q3 2020
11/16/2020
4.36-0.40-1.60NA
Q2 2020
8/14/2020
3.35-0.45-1.80NA
Q1 2020
5/15/2020
2.60-0.37-1.48NA
Q4 2019
3/13/2020
4.10-0.45-1.80NA
Q3 2019
11/8/2019
4.44-0.46-1.84NA
Q2 2019
8/9/2019
5.37-0.49-1.96NA
Q1 2019
5/10/2019
5.65-0.36-1.44NA
Q4 2018
3/8/2019
5.32-0.31-1.24NA
Q3 2018
11/9/2018
3.85-0.39-1.56NA
Q2 2018
8/10/2018
3.59-0.41-1.64NA
Q1 2018
5/11/2018
4.35-0.40-1.60NA
PLx Pharma PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/10/2022
0.60-0.37-2.28NA
Q2 2022
8/12/2022
1.64-0.52-2.28NA
Q1 2022
5/13/2022
2.59-0.66-2.55NA
Q4 2021
3/11/2022
4.05-0.73-2.62NA
Q3 2021
11/12/2021
12.28-0.37-2.76NA
Q2 2021
8/6/2021
19.09-0.79-2.79NA
Q1 2021
5/14/2021
11.07-0.73-2.45NA
Q4 2020
3/12/2021
7.98-0.87-2.09NA
Q3 2020
11/16/2020
4.36-0.40-1.67NA
Q2 2020
8/14/2020
3.35-0.45-1.73NA
Q1 2020
5/15/2020
2.60-0.37-1.77NA
Q4 2019
3/13/2020
4.10-0.45-1.76NA
Q3 2019
11/8/2019
4.44-0.46-1.62NA
Q2 2019
8/9/2019
5.37-0.49-1.55NA
Q1 2019
5/10/2019
5.65-0.36-1.47NA
Q4 2018
3/8/2019
5.32-0.31-1.51NA
Q3 2018
11/9/2018
3.85-0.39NANA
Q2 2018
8/10/2018
3.59-0.41NANA
Q1 2018
5/11/2018
4.35-0.40NANA
Quotes delayed 20 minutes

Email EnvelopeFree PLXP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
PLx Pharma (PLXP) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PMCB PE Ratio History
PMD PE Ratio History
PMVP PE Ratio History
POAI PE Ratio History
PODD PE Ratio History
PRAH PE Ratio History
PRAX PE Ratio History
PRCT PE Ratio History
PRGO PE Ratio History
PRLD PE Ratio History
How should the PLXP historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like PLx Pharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PLXP Historical PE Ratio page.

What is the average historical PE for PLXP based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PLXP historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for PLXP based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PLXP historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the PLx Pharma Historical PE Ratio information for PLx Pharma' stock. The average PLXP historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PLXP historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PLXP historical PE result, against the recent PE: when this page was posted on 11/10/2022, the most recent closing price for PLXP had been 0.60, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on PLXP or any other given stock, valuation analysis for PLXP can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate PLx Pharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PLXP. Thanks for visiting, and the next time you need to research PLXP Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: MWK market cap history, BSJS shares outstanding history, Institutional Holders of BGG.

 

PLx Pharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.